The Significance of Stereotyped B-Cell Receptors in Chronic Lymphocytic Leukemia

Hematology/Oncology Clinics of North America

Volumn 27, Issue 2, 2013, Pages 237-250

  Darzentas, Nikos ^a,b   Stamatopoulos, Kostas ^b,c  

^a MASARYK UNIVERSITY   (Czech Republic)

^b INFORMATION TECHNOLOGIES INSTITUTE   (Greece)

^c G PAPANICOLAOU HOSPITAL   (Greece)

Author keywords

Antigen; CDR3; CLL; Immunoglobulin gene; Somatic hypermutation; Stereotype; Subset

Indexed keywords

B LYMPHOCYTE RECEPTOR; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN RECEPTOR; MONOCLONAL ANTIBODY;

ANTIBODY COMBINING SITE; CHRONIC LYMPHATIC LEUKEMIA; COMMENSAL; CYTOMEGALOVIRUS INFECTION; EPSTEIN BARR VIRUS INFECTION; GENE EXPRESSION; GENE MUTATION; IMMUNOGENICITY; IMMUNOGLOBULIN HEAVY CHAIN GENE; IMMUNOGLOBULIN PRODUCTION; LEUKEMIA CELL; ONTOGENY; PERSISTENT INFECTION; PRIORITY JOURNAL; REVIEW; SEQUENCE ALIGNMENT; STEREOTYPY; SYSTEMS BIOLOGY;

ANIMALS; ANTIBODY DIVERSITY; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOGLOBULINS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; RECEPTORS, ANTIGEN, B-CELL; SOMATIC HYPERMUTATION, IMMUNOGLOBULIN;

EID: 84875783393     PISSN: 08898588     EISSN: 15581977     Source Type: Journal    
DOI: 10.1016/j.hoc.2012.12.001     Document Type: Review

References (84)

1. Kuby J. Immunobiology 2001, WH Freeman, San Francisco, CA. 4th edition.
2. Janeway C., Travers P., Walport M., et al. The immune system in health and disease 2004, Garland, New York, NY. 6th edition.
3. Lefranc M.P., Lefranc G. The immunoglobulin FactsBook 2001, Academic Press, London, San Diego, CA.
4. Schatz D.G., Spanopoulou E. Biochemistry of V(D)J recombination. Curr Top Microbiol Immunol 2005, 290:49-85.
5. Schatz D.G., Swanson P.C. V(D)J recombination: mechanisms of initiation. Annu Rev Genet 2011, 45:167-202.
6. Schlissel M.S. Regulating antigen-receptor gene assembly. Nat Rev Immunol 2003, 3:890-899.
7. Maizels N. Immunoglobulin gene diversification. Annu Rev Genet 2005, 39:23-46.
8. Victora G.D., Nussenzweig M.C. Germinal centers. Annu Rev Immunol 2012, 30:429-457.
9. Shlomchik M.J., Weisel F. Germinal center selection and the development of memory B and plasma cells. Immunol Rev 2012, 247:52-63.
10. Xu Z., Zan H., Pone E.J., et al. Immunoglobulin class-switch DNA recombination: induction, targeting and beyond. Nat Rev Immunol 2012, 12:517-531.
11. Schroeder H.W., Dighiero G. The pathogenesis of chronic lymphocytic leukemia: analysis of the antibody repertoire. Immunol Today 1994, 15:288-294.
12. Efremov D.G., Ivanovski M., Siljanovski N., et al. Restricted immunoglobulin VH region repertoire in chronic lymphocytic leukemia patients with autoimmune hemolytic anemia. Blood 1996, 87:3869-3876.
13. Hashimoto S., Dono M., Wakai M., et al. Somatic diversification and selection of immunoglobulin heavy and light chain variable region genes in IgG+ CD5+ chronic lymphocytic leukemia B cells. J Exp Med 1995, 181:1507-1517.
14. Johnson T.A., Rassenti L.Z., Kipps T.J. Ig VH1 genes expressed in B cell chronic lymphocytic leukemia exhibit distinctive molecular features. J Immunol 1997, 158:235-246.
15. Fais F., Ghiotto F., Hashimoto S., et al. Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. J Clin Invest 1998, 102:1515-1525.
16. Hamblin T.J., Davis Z., Gardiner A., et al. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 1999, 94:1848-1854.
17. Damle R.N., Ghiotto F., Valetto A., et al. B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes. Blood 2002, 99:4087-4093.
18. Hillmen P. Using the biology of chronic lymphocytic leukemia to choose treatment. Hematology Am Soc Hematol Educ Program 2011, 2011:104-109.
19. Tobin G., Thunberg U., Johnson A., et al. Somatically mutated Ig V(H)3-21 genes characterize a new subset of chronic lymphocytic leukemia. Blood 2002, 99:2262-2264.
20. Thorselius M., Krober A., Murray F., et al. Strikingly homologous immunoglobulin gene rearrangements and poor outcome in VH3-21-utilizing chronic lymphocytic leukemia independent of geographical origin and mutational status. Blood 2006, 107:2889-2894.
21. Stamatopoulos K., Belessi C., Moreno C., et al. Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: pathogenetic implications and clinical correlations. Blood 2007, 109:259-270.
22. Bomben R., Dal Bo M., Capello D., et al. Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: results from an Italian multicentre study. Br J Haematol 2009, 144:492-506.
23. Oscier D., Wade R., Davis Z., et al. Prognostic factors identified three risk groups in the LRF CLL4 trial, independent of treatment allocation. Haematologica 2010, 95:1705-1712.
24. Tobin G., Thunberg U., Johnson A., et al. Chronic lymphocytic leukemias utilizing the VH3-21 gene display highly restricted Vlambda2-14 gene use and homologous CDR3s: implicating recognition of a common antigen epitope. Blood 2003, 101:4952-4957.
25. Messmer B.T., Albesiano E., Efremov D.G., et al. Multiple distinct sets of stereotyped antigen receptors indicate a role for antigen in promoting chronic lymphocytic leukemia. J Exp Med 2004, 200:519-525.
26. Widhopf G.F., Rassenti L.Z., Toy T.L., et al. Chronic lymphocytic leukemia B cells of more than 1% of patients express virtually identical immunoglobulins. Blood 2004, 104:2499-2504.
27. Tobin G., Thunberg U., Karlsson K., et al. Subsets with restricted immunoglobulin gene rearrangement features indicate a role for antigen selection in the development of chronic lymphocytic leukemia. Blood 2004, 104:2879-2885.
28. Stamatopoulos K., Belessi C., Hadzidimitriou A., et al. Immunoglobulin light chain repertoire in chronic lymphocytic leukemia. Blood 2005, 106:3575-3583.
29. Chiorazzi N., Ferrarini M. Cellular origin(s) of chronic lymphocytic leukemia: cautionary notes and additional considerations and possibilities. Blood 2011, 117:1781-1791.
30. Darzentas N., Hadzidimitriou A., Murray F., et al. A different ontogenesis for chronic lymphocytic leukemia cases carrying stereotyped antigen receptors: molecular and computational evidence. Leukemia 2010, 24(1):125-132.
31. Agathangelidis A., Darzentas N., Hadzidimitriou A., et al. Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies. Blood 2012, 119:4467-4475.
32. Murray F., Darzentas N., Hadzidimitriou A., et al. Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: implications for the role of antigen selection in leukemogenesis. Blood 2008, 111(3):1524-1533.
33. Kirkham P.M., Mortari F., Newton J.A., et al. Immunoglobulin VH clan and family identity predicts variable domain structure and may influence antigen binding. EMBO J 1992, 11:603-609.
34. Vargas-Madrazo E., Lara-Ochoa F., Ramirez-Benites M.C., et al. Evolution of the structural repertoire of the human V(H) and Vkappa germline genes. Int Immunol 1997, 9:1801-1815.
35. Sthoeger Z.M., Wakai M., Tse D.B., et al. Production of autoantibodies by CD5-expressing B lymphocytes from patients with chronic lymphocytic leukemia. J Exp Med 1989, 169:255-268.
36. Borche L., Lim A., Binet J.L., et al. Evidence that chronic lymphocytic leukemia B lymphocytes are frequently committed to production of natural autoantibodies. Blood 1990, 76:562-569.
37. Herve M., Xu K., Ng Y.S., et al. Unmutated and mutated chronic lymphocytic leukemias derive from self-reactive B cell precursors despite expressing different antibody reactivity. J Clin Invest 2005, 115:1636-1643.
38. Claflin J.L., Berry J. Genetics of the phosphocholine-specific antibody response to Streptococcus pneumoniae. Germ-line but not mutated T15 antibodies are dominantly selected. J Immunol 1988, 141:4012-4019.
39. Shaw P.X., Horkko S., Chang M.K., et al. Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity. J Clin Invest 2000, 105:1731-1740.
40. Baumgarth N., Tung J.W., Herzenberg L.A. Inherent specificities in natural antibodies: a key to immune defense against pathogen invasion. Springer Semin Immunopathol 2005, 26:347-362.
41. Kasaian M.T., Casali P. Autoimmunity-prone B-1 (CD5 B) cells, natural antibodies and self recognition. Autoimmunity 1993, 15:315-329.
42. Mouthon L., Nobrega A., Nicolas N., et al. Invariance and restriction toward a limited set of self-antigens characterize neonatal IgM antibody repertoires and prevail in autoreactive repertoires of healthy adults. Proc Natl Acad Sci U S A 1995, 92:3839-3843.
43. Baumgarth N., Herman O.C., Jager G.C., et al. Innate and acquired humoral immunities to influenza virus are mediated by distinct arms of the immune system. Proc Natl Acad Sci U S A 1999, 96:2250-2255.
44. Seidl K., Wilshire J., MacKenzie J., et al. Predominant VH genes expressed in innate antibodies are associated with distinctive antigen-binding sites. Proc Natl Acad Sci U S A 1999, 96:2262-2267.
45. Seidl K., MacKenzie J., Wang D., et al. Frequent occurrence of identical heavy and light chain Ig rearrangements. Int Immunol 1997, 9:689-702.
46. Milner E.C., Anolik J., Cappione A., et al. Human innate B cells: a link between host defense and autoimmunity?. Springer Semin Immunopathol 2005, 26:433-452.
47. Jirholt P., Ohlin M., Borrebaeck C.A., et al. Exploiting sequence space: shuffling in vivo formed complementarity determining regions into a master framework. Gene 1998, 215:471-476.
48. Scheid J.F., Mouquet H., Ueberheide B., et al. Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding. Science 2011, 333:1633-1637.
49. Bichi R., Shinton S.A., Martin E.S., et al. Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression. Proc Natl Acad Sci U S A 2002, 99:6955-6960.
50. ter Brugge P.J., Ta V.B., de Bruijn M.J., et al. A mouse model for chronic lymphocytic leukemia based on expression of the SV40 large T antigen. Blood 2009, 114:119-127.
51. Bertilaccio M.T., Scielzo C., Simonetti G., et al. A novel Rag2-/-gammac-/- xenograft model of human CLL. Blood 2010, 115:1605-1609.
52. Salerno E., Yuan Y., Scaglione B., et al. The New Zealand black mouse as a model for the development and progression of chronic lymphocytic leukemia. Cytometry B Clin Cytom 2010, 78(Suppl 1):S98-S109.
53. Lia M., Carette A., Tang H., et al. Functional dissection of the chromosome 13q14 tumor-suppressor locus using transgenic mouse lines. Blood 2012, 119:2981-2990.
54. Yan X.J., Albesiano E., Zanesi N., et al. B cell receptors in TCL1 transgenic mice resemble those of aggressive, treatment-resistant human chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 2006, 103:11713-11718.
55. Mercolino T.J., Locke A.L., Afshari A., et al. Restricted immunoglobulin variable region gene usage by normal Ly-1 (CD5+) B cells that recognize phosphatidyl choline. J Exp Med 1989, 169(6):1869-1877.
56. Hardy R.R. B-1 B cell development. J Immunol 2006, 177(5):2749-2754.
57. Wang H., Clarke S. Evidence for a ligand-mediated positive selection signal in differentiation to a mature B cell. J Immunol 2003, 171:6381-6388.
58. Wang H., Clarke S.H. Positive selection focuses the VH12 B-cell repertoire towards a single B1 specificity with survival function. Immunol Rev 2004, 197:51-59.
59. Lanemo Myhrinder A., Hellqvist E., Sidorova E., et al. A new perspective: molecular motifs on oxidized LDL, apoptotic cells, and bacteria are targets for chronic lymphocytic leukemia antibodies. Blood 2008, 111:3838-3848.
60. Hatzi K., Catera R., Ferrarini M., et al. B-cell chronic lymphocytic leukemia (B-CLL) cells express antibodies reactive with antigenic epitopes expressed on the surface of common bacteria. Blood 2006, 108:12a.
61. Catera R., Silverman G.J., Hatzi K., et al. Chronic lymphocytic leukemia cells recognize conserved epitopes associated with apoptosis and oxidation. Mol Med 2008, 14:665-674.
62. Chu C.C., Catera R., Hatzi K., et al. Chronic lymphocytic leukemia antibodies with a common stereotypic rearrangement recognize nonmuscle myosin heavy chain IIA. Blood 2008, 112:5122-5129.
63. Chu C.C., Catera R., Zhang L., et al. Many chronic lymphocytic leukemia antibodies recognize apoptotic cells with exposed non-muscle myosin heavy chain IIA: implications for patient outcome and cell of origin. Blood 2010, 115:3907-3915.
64. Landgren O., Rapkin J., Caporaso N., et al. Respiratory tract infections and subsequent risk of chronic lymphocytic leukemia. Blood 2007, 109:2198-2201.
65. Kostareli E., Hadzidimitriou A., Stavroyianni N., et al. Molecular evidence for EBV and CMV persistence in a subset of patients with chronic lymphocytic leukemia expressing stereotyped IGHV4-34 B-cell receptors. Leukemia 2009, 23:919-924.
66. Jang Y.J., Stollar B.D. Anti-DNA antibodies: aspects of structure and pathogenicity. Cell Mol Life Sci 2003, 60:309-320.
67. Hadzidimitriou A., Darzentas N., Murray F., et al. Evidence for the significant role of immunoglobulin light chains in antigen recognition and selection in chronic lymphocytic leukemia. Blood 2009, 113:403-411.
68. Li H., Jiang Y., Prak E.L., et al. Editors and editing of anti-DNA receptors. Immunity 2001, 15:947-957.
69. Zhang J., Jacobi A.M., Wang T., et al. Pathogenic autoantibodies in systemic lupus erythematosus are derived from both self-reactive and non-self-reactive B cells. Mol Med 2008, 14:675-681.
70. Potter K., Hobby P., Klijn S., et al. Evidence for involvement of a hydrophobic patch in framework region 1 of human V4-34-encoded Igs in recognition of the red blood cell I antigen. J Immunol 2002, 169:3777-3782.
71. Sutton L.A., Kostareli E., Hadzidimitriou A., et al. Extensive intraclonal diversification in a subgroup of chronic lymphocytic leukemia patients with stereotyped IGHV4-34 receptors: implications for ongoing interactions with antigen. Blood 2009, 114:4460-4468.
72. Kostareli E., Sutton L., Hadzidimitriou A., et al. Intraclonal diversification of immunoglobulin light chains in a subset of chronic lymphocytic leukemia alludes to antigen-driven clonal evolution. Leukemia 2010, 24:1317-1324.
73. Cerutti A., Puga I., Cols M. Innate control of B cell responses. Trends Immunol 2011, 32:202-211.
74. Meyer-Bahlburg A., Khim S., Rawlings D.J. B cell intrinsic TLR signals amplify but are not required for humoral immunity. J Exp Med 2007, 204:3095-3101.
75. Arvaniti E., Ntoufa S., Papakonstantinou N., et al. Toll-like receptor signaling pathway in chronic lymphocytic leukemia: distinct gene expression profiles of potential pathogenetic significance in specific subsets of patients. Haematologica 2011, 96:1644-1652.
76. Ntoufa S., Vardi A., Papakonstantinou N., et al. Distinct innate immunity pathways to activation and tolerance in subgroups of chronic lymphocytic leukemia with distinct immunoglobulin receptors. Mol Med 2012, 18:1281-1291.
77. Minden M.D., Ubelhart R., Schneider D., et al. Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signalling. Nature 2012, 489:309-312.
78. Campbell P., Pleasance E., Stephens P., et al. Subclonal phylogenetic structures in cancer revealed by ultra-deep sequencing. Proc Natl Acad Sci U S A 2008, 105:13081-13086.
79. Bomben R., Dal-Bo M., Benedetti D., et al. Expression of mutated IGHV3-23 genes in chronic lymphocytic leukemia identifies a disease subset with peculiar clinical and biological features. Clin Cancer Res 2010, 16:620-628.
80. Matthews C., Catherwood M., Morris T., et al. V(H)3-48 and V(H)3-53, as well as V(H)3-21, gene rearrangements define unique subgroups in CLL and are associated with biased lambda light chain restriction, homologous LCDR3 sequences and poor prognosis. Leuk Res 2007, 31:231-234.
81. Ghia P., Stamatopoulos K., Belessi C., et al. Geographic patterns and pathogenetic implications of IGHV gene usage in chronic lymphocytic leukemia: the lesson of the IGHV3-21 gene. Blood 2005, 105:1678-1685.
82. Ghiotto F., Fais F., Valetto A., et al. Remarkably similar antigen receptors among a subset of patients with chronic lymphocytic leukemia. J Clin Invest 2004, 113:1008-1016.
83. Rossi D., Spina V., Cerri M., et al. Stereotyped B-cell receptor is an independent risk factor of chronic lymphocytic leukemia transformation to Richter syndrome. Clin Cancer Res 2009, 15:4415-4422.
84. Potter K.N., Mockridge C.I., Neville L., et al. Structural and functional features of the B-cell receptor in IgG-positive chronic lymphocytic leukemia. Clin Cancer Res 2006, 12:1672-1679.